Kreyenberg H - Search Results

1

CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.

Kuçi S, Kuçi Z, Kreyenberg H, Deak E, Pütsch K, Huenecke S, Amara C, Koller S, Rettinger E, Grez M, Koehl U, Latifi-Pupovci H, Henschler R, Tonn T, von Laer D, Klingebiel T, Bader P. Kuçi S, et al. Among authors: kreyenberg h. Haematologica. 2010 Apr;95(4):651-9. doi: 10.3324/haematol.2009.015065. Epub 2010 Feb 23. Haematologica. 2010. PMID: 20179086 Free PMC article.

2

[Relapse of childhood ALL, AML and MDS after allogeneic stem cell transplantation can be prevented by donor lymphocyte infusion in a critical stage of increasing mixed chimerism].

Beck JF, Klingebiel T, Kreyenberg H, Schaudt A, Wölle W, Niethammer D, Bader P. Beck JF, et al. Among authors: kreyenberg h. Klin Padiatr. 2002 Jul-Aug;214(4):201-5. doi: 10.1055/s-2002-33176. Klin Padiatr. 2002. PMID: 12165902 Clinical Trial. German.

3

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

Bader P, Hancock J, Kreyenberg H, Goulden NJ, Niethammer D, Oakhill A, Steward CG, Handgretinger R, Beck JF, Klingebiel T. Bader P, et al. Among authors: kreyenberg h. Leukemia. 2002 Sep;16(9):1668-72. doi: 10.1038/sj.leu.2402552. Leukemia. 2002. PMID: 12200679

4

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience.

Kreyenberg H, Hölle W, Möhrle S, Niethammer D, Bader P. Kreyenberg H, et al. Leukemia. 2003 Jan;17(1):237-40. doi: 10.1038/sj.leu.2402761. Leukemia. 2003. PMID: 12529686 Review. No abstract available.

5

Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias.

Bader P, Dückers G, Kreyenberg H, Hoelle W, Kerst G, Lang P, Greil J, Niethammer D, Beck LF, Klingebiel T. Bader P, et al. Among authors: kreyenberg h. Ann Hematol. 2002;81 Suppl 2:S25-7. Ann Hematol. 2002. PMID: 12611064 No abstract available.

6

Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.

Goulden N, Bader P, Van Der Velden V, Moppett J, Schilham M, Masden HO, Krejci O, Kreyenberg H, Lankester A, Révész T, Klingebiel T, Van Dongen J. Goulden N, et al. Among authors: kreyenberg h. Br J Haematol. 2003 Jul;122(1):24-9. doi: 10.1046/j.1365-2141.2003.04394.x. Br J Haematol. 2003. PMID: 12823342 Free article. Review.

7

Analysis of chimerism after stem cell transplantation.

Bader P, Kreyenberg H. Bader P, et al. Among authors: kreyenberg h. Methods Mol Med. 2004;91:247-64. doi: 10.1385/1-59259-433-6:247. Methods Mol Med. 2004. PMID: 14573941 No abstract available.

8

Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia.

Hoelle W, Beck JF, Dueckers G, Kreyenberg H, Lang P, Gruhn B, Führer M, Niethammer D, Klingebiel T, Bader P. Hoelle W, et al. Among authors: kreyenberg h. Bone Marrow Transplant. 2004 Jan;33(2):219-23. doi: 10.1038/sj.bmt.1704337. Bone Marrow Transplant. 2004. PMID: 14647253

9

Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective.

Bader P, Kreyenberg H, Hoelle W, Dueckers G, Kremens B, Dilloo D, Sykora KW, Niemeyer C, Reinhardt D, Vormoor J, Gruhn B, Lang P, Greil J, Handgretinger R, Niethammer D, Klingebiel T, Beck JF. Bader P, et al. Among authors: kreyenberg h. Bone Marrow Transplant. 2004 Apr;33(8):815-21. doi: 10.1038/sj.bmt.1704444. Bone Marrow Transplant. 2004. PMID: 14990984 Clinical Trial.

10

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, Lang P, Kremens B, Dilloo D, Sykora KW, Schrappe M, Niemeyer C, Von Stackelberg A, Gruhn B, Henze G, Greil J, Niethammer D, Dietz K, Beck JF, Klingebiel T. Bader P, et al. Among authors: kreyenberg h. J Clin Oncol. 2004 May 1;22(9):1696-705. doi: 10.1200/JCO.2004.05.198. J Clin Oncol. 2004. PMID: 15117992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters